Hot Pursuit     21-Sep-24
Glenmark Pharma’s Maharashtra facility clears USFDA inspection
Glenmark Pharmaceuticals has announced that its formulation manufacturing facility located in Chhatrapati Sambhaji Nagar (Aurangabad), Maharashtra, has successfully cleared the US Food and Drug Administration (USFDA) inspection with zero observations
The inspection was conducted from 9 September to 20 September 2024. In conclusion, the USFDA has issued Form 483 with zero observations.

Glenmark Pharmaceuticals is a global innovation-driven pharmaceutical company with presence across specialty, generics and OTC businesses.

The drug maker reported consolidated net profit of Rs 340.27 crore in Q1 FY25, significantly higher from Rs 14.48 crore in Q1 FY24. Revenue from operations increased 6.85% year on year (YoY) to Rs 3,244.19 crore in the quarter ended 30 June 2024.

The scrip declined 1.56% to ends at Rs 1,625.40 on Friday, 20 September 2024.

Previous News
  Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP
 ( Corporate News - 17-Apr-25   20:08 )
  Glenmark Pharma’s US arm set to launch generic Adderall tablets
 ( Hot Pursuit - 17-Apr-25   08:04 )
  Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
 ( Corporate News - 16-Apr-25   19:53 )
  Glenmark Pharmaceuticals Ltd slips for fifth straight session
 ( Hot Pursuit - 11-Apr-25   13:35 )
  Glenmark Pharmaceuticals announces change in senior management
 ( Corporate News - 07-Apr-25   09:00 )
  Glenmark launches Vancomycin Hydrochloride for injection USP in the USA
 ( Hot Pursuit - 01-Apr-25   10:31 )
  Glenmark Pharmaceuticals launches Vancomycin Hydrochloride for Injection USP
 ( Corporate News - 01-Apr-25   09:40 )
  Nifty trades above 23,250 mark; realty shares climb
 ( Market Commentary - Mid-Session 21-Mar-25   10:36 )
  Glenmark Pharma gains as arm gets USFDA nod for Olopatadine Ophthalmic solution
 ( Hot Pursuit - 21-Mar-25   09:49 )
  Glenmark Pharmaceuticals launches Empagliflozin in India
 ( Corporate News - 12-Mar-25   13:29 )
  Glenmark Pharma launches generic Empagliflozin in India
 ( Hot Pursuit - 12-Mar-25   11:38 )
Other Stories
  Rossari Biotech Q4 PAT rises to Rs 34 crore in FY25
  28-Apr-25   11:25
  India Cements Q4 net loss widens to Rs 76 cr in FY25
  28-Apr-25   11:20
  GRSE soars on approval of land lease deal
  28-Apr-25   11:11
  Tata Technologies gains after Q4 PAT climbs 12% QoQ to Rs 189 cr
  28-Apr-25   11:07
  Volumes jump at Hyundai Motor India Ltd counter
  28-Apr-25   11:00
  Force Motors jumps as Q4 PAT soars 210% YoY to Rs 435 cr; declares dividend of Rs 40/sh
  28-Apr-25   10:36
  Avantel slips as Q4 PAT slides 50% YoY to Rs 6 cr
  28-Apr-25   10:31
  UGRO Capital Q4 PAT rises 24% YoY to Rs 41 cr
  28-Apr-25   10:29
  DCB Bank rises after Q4 PAT climbs 14% YoY to Rs 177 cr
  28-Apr-25   10:09
  M&M edges higher after signing deal to acquire nearly 59% stake in SML Isuzu
  28-Apr-25   10:09
Back Top